Selected research
Market Outlook & Growth Opportunities
Global Infusion Software Market Outlook and Growth Opportunities 2026
Market perspective
The global Infusion Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Infusion Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Infusion Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Infusion Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Infusion Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Infusion Software market include B. Braun, Inovalon, Brightree, AlayaCare, Ivenix, CitusHealth, EpiSoft, Eitan Medical and ICU Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Infusion Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Infusion Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Infusion Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Infusion Software market.
Infusion Software Segment by Company
B. Braun
Inovalon
Brightree
AlayaCare
Ivenix
CitusHealth
EpiSoft
Eitan Medical
ICU Medical
Weinfuse
Universal Software Solutions
WellSky
DoseMeRx
MarketBox
Daycenta
Infusion Software Segment by Type
Dose Error Reduction Software (DERS)
Clinical Workflow Software
Others
Infusion Software Segment by Application
Hospital
Clinic
Home
Infusion Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Infusion Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Infusion Software key companies, revenue, market share, and recent developments.
3. To split the Infusion Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Infusion Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Infusion Software significant trends, drivers, influence factors in global and regions.
6. To analyze Infusion Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infusion Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infusion Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infusion Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infusion Software industry.
Chapter 3: Detailed analysis of Infusion Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Infusion Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Infusion Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Dose Error Reduction Software (DERS)
- Clinical Workflow Software
- Others
Applications
- Hospital
- Clinic
- Home
Companies covered
- B. Braun
- Inovalon
- Brightree
- AlayaCare
- Ivenix
- CitusHealth
- EpiSoft
- Eitan Medical
- ICU Medical
- Weinfuse
- Universal Software Solutions
- WellSky
- DoseMeRx
- MarketBox
- Daycenta
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Infusion Software Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Infusion Software Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Infusion Software Market Dynamics
- 2.1 Infusion Software Industry Trends
- 2.2 Infusion Software Industry Drivers
- 2.3 Infusion Software Industry Opportunities and Challenges
- 2.4 Infusion Software Industry Restraints
3 Infusion Software Market by Company
- 3.1 Global Infusion Software Company Revenue Ranking in 2025
- 3.2 Global Infusion Software Revenue by Company (2021-2026)
- 3.3 Global Infusion Software Company Ranking (2024-2026)
- 3.4 Global Infusion Software Company Manufacturing Base and Headquarters
- 3.5 Global Infusion Software Company Product Type and Application
- 3.6 Global Infusion Software Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Infusion Software Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Infusion Software Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Infusion Software Market by Type
- 4.1 Infusion Software Type Introduction
- 4.1.1 Dose Error Reduction Software (DERS)
- 4.1.2 Clinical Workflow Software
- 4.1.3 Others
- 4.2 Global Infusion Software Sales Value by Type
- 4.2.1 Global Infusion Software Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Infusion Software Sales Value by Type (2021-2032)
- 4.2.3 Global Infusion Software Sales Value Share by Type (2021-2032)
5 Infusion Software Market by Application
- 5.1 Infusion Software Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Home
- 5.2 Global Infusion Software Sales Value by Application
- 5.2.1 Global Infusion Software Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Infusion Software Sales Value by Application (2021-2032)
- 5.2.3 Global Infusion Software Sales Value Share by Application (2021-2032)
6 Infusion Software Regional Value Analysis
- 6.1 Global Infusion Software Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Infusion Software Sales Value by Region (2021-2032)
- 6.2.1 Global Infusion Software Sales Value by Region: 2021-2026
- 6.2.2 Global Infusion Software Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Infusion Software Sales Value (2021-2032)
- 6.3.2 North America Infusion Software Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Infusion Software Sales Value (2021-2032)
- 6.4.2 Europe Infusion Software Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Infusion Software Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Infusion Software Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Infusion Software Sales Value (2021-2032)
- 6.6.2 South America Infusion Software Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Infusion Software Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Infusion Software Sales Value Share by Country, 2025 VS 2032
7 Infusion Software Country-level Value Analysis
- 7.1 Global Infusion Software Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Infusion Software Sales Value by Country (2021-2032)
- 7.2.1 Global Infusion Software Sales Value by Country (2021-2026)
- 7.2.2 Global Infusion Software Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Infusion Software Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Infusion Software Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Infusion Software Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Infusion Software Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Infusion Software Sales Value Growth Rate (2021-2032)
- 7.7.2 France Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Infusion Software Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Infusion Software Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Infusion Software Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Infusion Software Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Infusion Software Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Infusion Software Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Infusion Software Sales Value Growth Rate (2021-2032)
- 7.14.2 China Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Infusion Software Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Infusion Software Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Infusion Software Sales Value Growth Rate (2021-2032)
- 7.17.2 India Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Infusion Software Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Infusion Software Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Infusion Software Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Infusion Software Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Infusion Software Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Infusion Software Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Infusion Software Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Infusion Software Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Infusion Software Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Infusion Software Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Infusion Software Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Infusion Software Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Infusion Software Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Infusion Software Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Infusion Software Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Infusion Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 B. Braun
- 8.1.1 B. Braun Company Information
- 8.1.2 B. Braun Business Overview
- 8.1.3 B. Braun Infusion Software Revenue and Gross Margin (2021-2026)
- 8.1.4 B. Braun Infusion Software Product Portfolio
- 8.1.5 B. Braun Recent Developments
- 8.2 Inovalon
- 8.2.1 Inovalon Company Information
- 8.2.2 Inovalon Business Overview
- 8.2.3 Inovalon Infusion Software Revenue and Gross Margin (2021-2026)
- 8.2.4 Inovalon Infusion Software Product Portfolio
- 8.2.5 Inovalon Recent Developments
- 8.3 Brightree
- 8.3.1 Brightree Company Information
- 8.3.2 Brightree Business Overview
- 8.3.3 Brightree Infusion Software Revenue and Gross Margin (2021-2026)
- 8.3.4 Brightree Infusion Software Product Portfolio
- 8.3.5 Brightree Recent Developments
- 8.4 AlayaCare
- 8.4.1 AlayaCare Company Information
- 8.4.2 AlayaCare Business Overview
- 8.4.3 AlayaCare Infusion Software Revenue and Gross Margin (2021-2026)
- 8.4.4 AlayaCare Infusion Software Product Portfolio
- 8.4.5 AlayaCare Recent Developments
- 8.5 Ivenix
- 8.5.1 Ivenix Company Information
- 8.5.2 Ivenix Business Overview
- 8.5.3 Ivenix Infusion Software Revenue and Gross Margin (2021-2026)
- 8.5.4 Ivenix Infusion Software Product Portfolio
- 8.5.5 Ivenix Recent Developments
- 8.6 CitusHealth
- 8.6.1 CitusHealth Company Information
- 8.6.2 CitusHealth Business Overview
- 8.6.3 CitusHealth Infusion Software Revenue and Gross Margin (2021-2026)
- 8.6.4 CitusHealth Infusion Software Product Portfolio
- 8.6.5 CitusHealth Recent Developments
- 8.7 EpiSoft
- 8.7.1 EpiSoft Company Information
- 8.7.2 EpiSoft Business Overview
- 8.7.3 EpiSoft Infusion Software Revenue and Gross Margin (2021-2026)
- 8.7.4 EpiSoft Infusion Software Product Portfolio
- 8.7.5 EpiSoft Recent Developments
- 8.8 Eitan Medical
- 8.8.1 Eitan Medical Company Information
- 8.8.2 Eitan Medical Business Overview
- 8.8.3 Eitan Medical Infusion Software Revenue and Gross Margin (2021-2026)
- 8.8.4 Eitan Medical Infusion Software Product Portfolio
- 8.8.5 Eitan Medical Recent Developments
- 8.9 ICU Medical
- 8.9.1 ICU Medical Company Information
- 8.9.2 ICU Medical Business Overview
- 8.9.3 ICU Medical Infusion Software Revenue and Gross Margin (2021-2026)
- 8.9.4 ICU Medical Infusion Software Product Portfolio
- 8.9.5 ICU Medical Recent Developments
- 8.10 Weinfuse
- 8.10.1 Weinfuse Company Information
- 8.10.2 Weinfuse Business Overview
- 8.10.3 Weinfuse Infusion Software Revenue and Gross Margin (2021-2026)
- 8.10.4 Weinfuse Infusion Software Product Portfolio
- 8.10.5 Weinfuse Recent Developments
- 8.11 Universal Software Solutions
- 8.11.1 Universal Software Solutions Company Information
- 8.11.2 Universal Software Solutions Business Overview
- 8.11.3 Universal Software Solutions Infusion Software Revenue and Gross Margin (2021-2026)
- 8.11.4 Universal Software Solutions Infusion Software Product Portfolio
- 8.11.5 Universal Software Solutions Recent Developments
- 8.12 WellSky
- 8.12.1 WellSky Company Information
- 8.12.2 WellSky Business Overview
- 8.12.3 WellSky Infusion Software Revenue and Gross Margin (2021-2026)
- 8.12.4 WellSky Infusion Software Product Portfolio
- 8.12.5 WellSky Recent Developments
- 8.13 DoseMeRx
- 8.13.1 DoseMeRx Company Information
- 8.13.2 DoseMeRx Business Overview
- 8.13.3 DoseMeRx Infusion Software Revenue and Gross Margin (2021-2026)
- 8.13.4 DoseMeRx Infusion Software Product Portfolio
- 8.13.5 DoseMeRx Recent Developments
- 8.14 MarketBox
- 8.14.1 MarketBox Company Information
- 8.14.2 MarketBox Business Overview
- 8.14.3 MarketBox Infusion Software Revenue and Gross Margin (2021-2026)
- 8.14.4 MarketBox Infusion Software Product Portfolio
- 8.14.5 MarketBox Recent Developments
- 8.15 Daycenta
- 8.15.1 Daycenta Company Information
- 8.15.2 Daycenta Business Overview
- 8.15.3 Daycenta Infusion Software Revenue and Gross Margin (2021-2026)
- 8.15.4 Daycenta Infusion Software Product Portfolio
- 8.15.5 Daycenta Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst